Study title: Randomized, double-blind, multicenter, 8-week study in adolescents with a DSM-IV diagnosis of schizophreniac and suffering from an acute episode (PANSS total score 60-120)
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Nervous System Diseases | |||||
| Brands: Please see report, Please see report | |||||
| MAH holders: Please see report, Please see report | |||||
| Assessment: | |||||
| Active substance: RISPERIDONE | |||||
| ATC code: | |||||
| Document link: RIS-USA-231_Interventional_Risperidone.xls | |||||
| Document date: 2011-09-21 | |||||
| Study number: RIS.USA-231 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | Y | |